Clinical Trial Update: Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the immunogenicity and safety of Tetraxim versus local DTP + IPV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• TETRAXIM (Diphtheria, Tetanus, Pertussis, Poliomyelitis, Haemophilus influenzae type b conjugate vaccine)
• local DTP + IPV vaccine

Snippet

Sponsor: Sanofi | Conditions: Pertussis, Diphtheria | Phase 3 | Status: COMPLETED